Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (BPPV)

Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (BPPV)

BPPV_CPGHeader

Leadership: Neil Bhattacharyya, MD (Chair), Reginald F. Baugh, MD (Assistant Chair), Laura Orvidas, MD (Assistant Chair), Richard Rosenfeld, MD, MPH (Methodologist) 

Guideline Development Group: David Barrs, MD, Leo J. Bronston, DC, MappSc, Stephen Cass, MD, MPH, Ara A. Chalian, MD, Alan L. Desmond, AuD, Jerry M. Earll, MD, Terry D. Fife, MD, Drew C. Fuller, MD, MPH, James O. Judge, MD, Nancy R. Mann, MD, Linda T. Schuring, MSN, RN, Robert W. P. Steiner, MD, PhD, Susan L. Whitney, PhD

This guideline was published as a supplement in the November 2008 issue of Otolaryngology–—Head and Neck Surgery.

The primary purposes of this guideline are to improve quality of care and outcomes for BPPV by improving the accurate and efficient diagnosis of BPPV, reducing the inappropriate use of vestibular suppressant medications, decreasing the inappropriate use of ancillary tests such as radiographic imaging and vestibular testing, and to promote the use of effective repositioning maneuvers for treatment. 

Endorsements: 

American Academy of Neurology (AAN) - Affirmation of Value April 2012
American Academy of Family Physicians Feb 2013
Society of Otorhinolaryngology and Head – Neck Nurses, Inc. Oct 2011
American Speech-Language-Hearing Association Nov 2011

Physician Resources

For Patients

  • Plain Language Summary (Coming Soon)

For Media & Public